2020 ASCO Virtual Scientific Meeting*

May 29-31, 2020; Online at meetings.asco.org/am
Review slidesets and expert analyses of key data from the 2020 Clinical Oncology Virtual Scientific Meeting!
Ian W. Flinn, MD, PhD
Axel Grothey Headshot
Axel Grothey, MD
Sara Hurvitz, MD, FACP
Shaji Kumar, MD
Stephen V. Liu, MD
Bradley J. Monk, MD, FACS, FACOG
Daniel P. Petrylak, MD
Zofia Piotrowska, MD, MHS
Elizabeth R. Plimack, MD, MS
Farhad Ravandi, MD
Manish A. Shah, MD

ClinicalThought

Experts highlight key studies being presented at the upcoming 2020 ASCO virtual meeting. The CCO ASCO Virtual Conference Coverage program will have the information you need to understand and integrate the latest oncology data into your practice.

Ian W. Flinn, MD, PhD Axel Grothey Headshot Axel Grothey, MD Sara Hurvitz, MD, FACP Shaji Kumar, MD Stephen V. Liu, MD Bradley J. Monk, MD, FACS, FACOG Daniel P. Petrylak, MD Zofia Piotrowska, MD, MHS Elizabeth R. Plimack, MD, MS Farhad Ravandi, MD Manish A. Shah, MD Released: May 27, 2020
Provided by Clinical Care Options, LLC.

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
AbbVie Inc.
AstraZeneca
Bayer HealthCare Pharmaceuticals Inc.
Bristol-Myers Squibb
Daiichi Sankyo, Inc.
Exelixis
GlaxoSmithKline
Ipsen Biopharmaceuticals, Inc.
Jazz Pharmaceuticals
Karyopharm Therapeutics
Merck Sharp & Dohme Corp.
Novartis Pharmaceuticals Corporation
Pfizer, Inc. and EMD Serono

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue